Gianluigi De Renzi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?	BIOMEDICINES	2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer	FRONTIERS IN ONCOLOGY	2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer	CELLS	2023
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study	CANCERS	2022
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity	CANCER DRUG RESISTANCE	2022
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature	CANCER LETTERS	2021
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients	CANCERS	2021
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments	DIAGNOSTICS	2021
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights	ONCOLOGY	2020
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients	CANCERS	2020

Progetti di Ricerca

Evaluation of the differences between radioresistant and radiosensitive prostate tumor cell lines: a first step to unravel the mechanisms of radioresistance.